• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SAE:临床试验中用于提前停止规则的 R 包。

SAE: an R package for early stopping rules in clinical trials.

机构信息

Unité de Biostatistique, CRLC Val d'Aurelle - Paul Lamarque, 34298 Montpellier, France.

出版信息

Comput Methods Programs Biomed. 2011 Nov;104(2):243-8. doi: 10.1016/j.cmpb.2011.05.005. Epub 2011 Jul 7.

DOI:10.1016/j.cmpb.2011.05.005
PMID:21741110
Abstract

In the case of an unexpected high frequency of serious adverse events (SAE), statistical methods are needed to help in the decision making process as to continuation of accrual to the trial. This paper describes an R package, named SAE that implements a method recently developed by defining stopping rules after each observed SAE. The package function control for excessive toxicity either during the trial at the observation of each SAE (function SAE) or during the planning phase of a clinical trial (function DESIGN). This description and the package documentation are complementary to help the users to apply the method. The main difficulty in the implementation of the method is the choice of a priori parameters. Data from an ongoing clinical trial are presented as an example to improve the understanding and the use of the package.

摘要

在严重不良事件(SAE)发生频率出乎意料高的情况下,需要使用统计方法来帮助决策是否继续进行试验入组。本文描述了一个名为 SAE 的 R 包,该包实现了一种最近开发的方法,通过在每次观察到 SAE 后定义停止规则来实现。该包的函数在试验期间(函数 SAE)或临床试验规划阶段(函数 DESIGN)控制过度毒性。本说明和包文档是互补的,以帮助用户应用该方法。该方法实施的主要难点是先验参数的选择。目前正在进行的临床试验的数据作为示例,以提高对包的理解和使用。

相似文献

1
SAE: an R package for early stopping rules in clinical trials.SAE:临床试验中用于提前停止规则的 R 包。
Comput Methods Programs Biomed. 2011 Nov;104(2):243-8. doi: 10.1016/j.cmpb.2011.05.005. Epub 2011 Jul 7.
2
Early stopping rules in clinical trials based on sequential monitoring of serious adverse events.基于对严重不良事件的序贯监测的临床试验中的早期终止规则。
Med Decis Making. 2009 May-Jun;29(3):343-50. doi: 10.1177/0272989X08327332. Epub 2008 Dec 10.
3
Monitoring rare serious adverse events from a new treatment and testing for a difference from historical controls.监测新疗法罕见的严重不良事件,并检测与历史对照的差异。
Clin Trials. 2007;4(6):598-610. doi: 10.1177/1740774507084978.
4
Phase II stopping rules that employ response rates and early progression.采用缓解率和早期进展情况的II期试验终止规则。
J Clin Oncol. 2008 Aug 1;26(22):3715-20. doi: 10.1200/JCO.2007.14.1044.
5
Continuous safety monitoring for randomized controlled clinical trials with blinded treatment information. Part 4: One method.随机对照临床试验的连续性安全性监测,设盲治疗信息。第 4 部分:一种方法。
Contemp Clin Trials. 2011 Sep;32 Suppl 1:S11-7. doi: 10.1016/j.cct.2011.05.008. Epub 2011 Jun 1.
6
Nomograms to predict serious adverse events in phase II clinical trials of molecularly targeted agents.用于预测分子靶向药物II期临床试验中严重不良事件的列线图。
J Clin Oncol. 2008 Mar 10;26(8):1324-30. doi: 10.1200/JCO.2007.14.0673.
7
New adaptive method for phase I trials in oncology.肿瘤学I期试验的新型自适应方法。
Clin Pharmacol Ther. 2008 Jun;83(6):873-81. doi: 10.1038/sj.clpt.6100383. Epub 2007 Oct 24.
8
[State of the art and therapeutic prospects in neuroectodermal tumours and other neuroendocrine pathologies].[神经外胚层肿瘤及其他神经内分泌疾病的研究现状与治疗前景]
Minerva Endocrinol. 2001 Dec;26(4):215-24.
9
The role of high-dose chemotherapy and stem cell rescue in the treatment of malignant brain tumors.大剂量化疗和干细胞救援在恶性脑肿瘤治疗中的作用。
Bone Marrow Transplant. 1996 Dec;18 Suppl 3:S1-5.
10
Some ethical issues in phase II trials in acute leukemia.急性白血病II期试验中的一些伦理问题。
Clin Adv Hematol Oncol. 2005 Dec;3(12):943-8.

引用本文的文献

1
GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study.胃切除和腹腔内热灌注化疗治疗局部进展期胃癌:一项随机多中心 III 期研究。
BMC Cancer. 2014 Mar 14;14:183. doi: 10.1186/1471-2407-14-183.